Cargando…

Increased COVID-19 breakthrough infection risk in patients with plasma cell disorders

Detalles Bibliográficos
Autores principales:	La, Jennifer, Wu, Julie Tsu-Yu, Branch-Elliman, Westyn, Huhmann, Linden, Han, Summer S., Brophy, Mary, Do, Nhan V., Lin, Albert Y., Fillmore, Nathanael R., Munshi, Nikhil C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Letter to Blood
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130311/ https://www.ncbi.nlm.nih.gov/pubmed/35605185 http://dx.doi.org/10.1182/blood.2022016317

Ejemplares similares

Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study
por: Fillmore, Nathanael R, et al.
Publicado: (2022)

Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders
por: Fillmore, Nathanael R., et al.
Publicado: (2023)

Inadequate Sars-Cov-2 Vaccine Effectiveness in Patients with Multiple Myeloma: A Large Nationwide Veterans Affairs Study
por: Fillmore, Nathanael R, et al.
Publicado: (2021)

Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs Study
por: Wu, Julie Tsu-Yu, et al.
Publicado: (2021)

Factors associated with the speed and scope of diffusion of COVID-19 therapeutics in a nationwide healthcare setting: a mixed-methods investigation
por: La, Jennifer, et al.
Publicado: (2022)

Recent common human coronavirus infection protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A Veterans Affairs cohort study
por: Fillmore, Nathanael R., et al.
Publicado: (2022)

Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals
por: Vo, Austin D., et al.
Publicado: (2022)

Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study
por: Li, Lucy L., et al.
Publicado: (2022)

1562MO Effectiveness of COVID-19 vaccination in cancer patients: A nationwide Veterans Affairs study
por: Wu, J.T-Y., et al.
Publicado: (2021)

2656. Longitudinal Trends in Attributable Causes of Death Among US Veteran Patients with Documented SARS-CoV-2 Infection between January 2021 and March 2023
por: Trottier, Caitlin A, et al.
Publicado: (2023)

Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study
por: Fillmore, Nathanael R, et al.
Publicado: (2020)

Umbilical Cord Blood Units Cryopreserved in the Public Cord Blood Bank: A Breakthrough in iPSC Haplobanking?
por: Roh, Eun Youn, et al.
Publicado: (2020)

Automating surveillance for healthcare-associated infections: Rationale and current realities (Part I/III)
por: Shenoy, Erica S., et al.
Publicado: (2023)

Pandemic scientific data sharing recommendations: examining and re-imagining pre-print servers after the end of the world-wide emergency
por: Doron, Shira, et al.
Publicado: (2023)

Reconsidering ‘minimal risk’ to expand the repertoire of trials with waiver of informed consent for research
por: Monach, Paul A, et al.
Publicado: (2021)

More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants
por: Monach, Paul A, et al.
Publicado: (2023)

Moving towards a precision approach for prevention of severe COVID-19
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

Economic Considerations in Infectious Diseases Emergency Response Preparedness: It’s All About the Point of View
por: Branch-Elliman, Westyn, et al.
Publicado: (2020)

1101. What Do Electrophysiologists Think about Peri-Procedural Antibiotics? A Qualitative Assessment of Factors Driving Use and Facilitators for Implementing Change
por: Branch-Elliman, Westyn, et al.
Publicado: (2019)

The next ‘pandemic playbook’ needs to prioritize the needs of children—and a clear roadmap for opening schools
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

111. Increasing Duration of Surgical Prophylaxis Increases Antimicrobial-Associated Adverse Events but Does Not Decrease Surgical Site Infections: An Opportunity for Stewardship
por: Strymish, Judith M, et al.
Publicado: (2018)

Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers
por: Roth, Nathan J., et al.
Publicado: (2020)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

Plasmavigilance—Adverse events among US Source plasma donors
por: Schreiber, George B., et al.
Publicado: (2021)

Risk factors of SARS-CoV-2 infection and complications from COVID-19 in lung cancer patients
por: Ganti, Apar Kishor, et al.
Publicado: (2023)

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
por: Tedder, Richard S., et al.
Publicado: (2018)

Bringing New Meaning to the Term “Adaptive Trial”: Challenges of Conducting Clinical Research During the Coronavirus Disease 2019 Pandemic and Implications for Implementation Science
por: Branch-Elliman, Westyn, et al.
Publicado: (2020)

Using the Pillars of Infection Prevention to Build an Effective Program for Reducing the Transmission of Emerging and Reemerging Infections
por: Branch-Elliman, Westyn, et al.
Publicado: (2015)

Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs System
por: La, Jennifer, et al.
Publicado: (2020)

2126. Comparative Effectiveness of Infection Prevention Interventions for Reducing Procedure-Related Cardiac Device Infections: Insights from the VA CART Program
por: Asundi, Archana, et al.
Publicado: (2018)

Embracing dynamic public health policy impacts in infectious diseases responses: leveraging implementation science to improve practice
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

Personalized collection of plasma from healthy donors: A randomized controlled trial of a novel technology‐enabled nomogram
por: Hartmann, Jan, et al.
Publicado: (2021)

Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men
por: Castillo, Gisell, et al.
Publicado: (2022)

What would it take to convince you to donate? A survey study of the relationship between motivators, barriers, and payment for whole blood, plasma, and platelet donation
por: France, Christopher R., et al.
Publicado: (2022)

How to increase first‐time donors' returns? The postdonation letter's content can make a difference
por: Moussaoui, Lisa S., et al.
Publicado: (2022)

Use of convalescent plasma in hospitalized patients with COVID-19: case series
por: Hegerova, Livia, et al.
Publicado: (2020)

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?
por: Frigault, Matthew J., et al.
Publicado: (2020)

The future of automated infection detection: Innovation to transform practice (Part III/III)
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

Leveraging electronic data to expand infection detection beyond traditional settings and definitions (Part II/III)
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

How should we use convalescent plasma therapies for the management of COVID-19?
por: Wood, Erica M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rd88k6njfkd9kjuede8e7avdc4